Reduced interleukin-6 immunoexpression and birefringent collagen formation indicate that MTA Plus and MTA Fillapex are biocompatible
- 20 February 2018
- journal article
- research article
- Published by IOP Publishing in Biomedical Materials
- Vol. 13 (3) , 035002
Abstract
Considering that endodontic sealers release some components which may promote delay in the repair process, our purpose was to evaluate the tissue reaction promoted by MTA Plus and MTA Fillapex in comparison with AH Plus (standard control) and Endofill, which has a long clinical track record. One hundred rats were distributed into five groups: MTA Plus (Avalon Biom Inc., Bradenton, FL, USA), MTA Fillapex (Angelus, Londrina, PR, Brazil), AH Plus (Dentsply DeTrey GmbH, Konstanz, Germany), Endofill (Dentsply, Petrópolis, RJ, Brazil) and CG (control group, empty polyethylene tubes). The polyethylene tubes filled with sealers or empty (CG) were implanted into subcutaneous. After 7, 15, 30 and 60 days, the tubes surrounded by capsules were paraffin-embedded. In HE-stained sections, the volume density of inflammatory cells (VvIC) was estimated in the capsules. The number of interleukin-6-immunolabelled cells (IL-6), a pro-inflammatory cytokine, was also computed in the capsules. The birefringent collagen content was quantified in picrosirius-stained sections. Data were analysed by ANOVA and Tukey tests ( p ≤ 0.05). At 7 days, the capsules showed moderate inflammatory reaction. In all groups, VvIC and IL-6-immunostained cells reduced significantly from 7 to 60 days. At 60 days, IL-6 immunoexpression was reduced significantly in MTA Plus and MTA Fillapex in comparison with AH Plus; no difference was found in the VvIC among MTA Plus, MTA Fillapex, AH Plus and CG whereas Endofill exhibited the highest VvIC. The reduction in VvIC was parallel to an increase in the collagen in all the groups, except Endofill. MTA Plus, MTA Fillapex and AH Plus induce a response that culminates in the regression of inflammation and formation of a fibrous capsule over time. The lower IL-6 immunoexpression in the capsules of MTA Plus and MTA Fillapex than AH Plus suggests that the immune response is suppressed more rapidly in the MTA-based sealers.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado do Amazonas
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
This publication has 53 references indexed in Scilit:
- Bioactivity of MTA Plus, Biodentine and an experimental calcium silicate‐based cement on human osteoblast‐like cellsInternational Endodontic Journal, 2015
- Niobium pentoxide as radiopacifying agent of calcium silicate-based material: evaluation of physicochemical and biological propertiesClinical Oral Investigations, 2015
- Chemical characterization and bioactivity of epoxy resin and Portland cement-based sealers with niobium and zirconium oxide radiopacifiersDental Materials, 2014
- Biocompatibility of an experimental MTA sealer implanted in the rat subcutaneous: Quantitative and immunohistochemical evaluationJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2012
- Niobium pentoxide as a new filler for methacrylate‐based root canal sealersInternational Endodontic Journal, 2012
- Histological and histomorphometrical evaluation of furcation perforations filled with MTA, CPM and ZOEInternational Endodontic Journal, 2010
- Histopathological evaluation of root canal filling materials for primary teethBrazilian Dental Journal, 2010
- Evaluation of Mineral Trioxide Aggregate and Calcium Hydroxide Cement as Pulp-capping Agents in Human TeethJournal of Endodontics, 2008
- Comparative investigation of marginal adaptation of mineral trioxide aggregate and other commonly used root-end filling materialsJournal of Endodontics, 1995
- Sealing ability of a mineral trioxide aggregate for repair of lateral root perforationsJournal of Endodontics, 1993